STRS Ohio’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

STRS Ohio’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-478,470	Closed	-$55.4M	–	2057
2023 Q3	$55.4M	Sell	478,470 -213,209	-31%	-$22.9M	0.25%	89
2023 Q2	$71.1M	Sell	691,679 -23,902	-3%	-$2.52M	0.3%	73
2023 Q1	$78.1M	Buy	715,581 +12,081	+2%	+$1.34M	0.34%	63
2022 Q4	$80.1M	Sell	703,500 -12,000	-2%	-$997K	0.36%	59
2022 Q3	$44.3M	Buy	715,500 +5,994	+0.8%	+$419K	0.21%	122
2022 Q2	$56.6M	Buy	709,506 +126,787	+22%	+$12M	0.25%	98
2022 Q1	$61.3M	Buy	582,719 +101,880	+21%	+$9.93M	0.22%	106
2021 Q4	$51.8M	Buy	480,839 +112,337	+30%	+$12.3M	0.18%	134
2021 Q3	$40.4M	Buy	368,502 +205,886	+127%	+$21.4M	0.15%	165
2021 Q2	$15.2M	Sell	162,616 -7,605	-4%	-$700K	0.05%	335
2021 Q1	$15.7M	Buy	170,221 +16,674	+11%	+$1.41M	0.06%	316
2020 Q4	$11.2M	Buy	153,547 +139,665	+1,006%	+$10.4M	0.04%	363
2020 Q3	$1.08M	Sell	13,882 -10,647	-43%	-$733K	﹤0.01%	889
2020 Q2	$1.36M	Buy	24,529 +4,396	+22%	+$188K	0.01%	746
2020 Q1	$596K	Buy	20,133 +999	+5%	+$33.8K	﹤0.01%	1011
2019 Q4	$692K	Buy	19,134 +7,133	+59%	+$219K	﹤0.01%	1188
2019 Q3	$326K	Sell	12,001 -627	-5%	-$16.2K	﹤0.01%	1499
2019 Q2	$303K	Sell	12,628 -15,372	-55%	-$390K	﹤0.01%	1579
2019 Q1	$740K	Buy	28,000 +7,500	+37%	+$178K	﹤0.01%	971
2018 Q4	$400K	Buy	20,500 +7,600	+59%	+$149K	﹤0.01%	1370
2018 Q3	$252K	Buy	12,900 +2,100	+19%	+$39.9K	﹤0.01%	1668
2018 Q2	$178K	Buy	10,800 +4,600	+74%	+$70.1K	﹤0.01%	1774
2018 Q1	$88K	Hold	6,200	–	–	﹤0.01%	1646
2017 Q4	$90K	Buy	+6,200	New	+$87.1K	﹤0.01%	1648
2017 Q3	–	Sell	-9,000	Closed	-$106K	–	2003
2017 Q2	$106K	Hold	9,000	–	–	﹤0.01%	1622
2017 Q1	$133K	Sell	9,000 -2,200	-20%	-$35.6K	﹤0.01%	1589
2016 Q4	$181K	Sell	11,200 -10,600	-49%	-$192K	﹤0.01%	1563
2016 Q3	$395K	Buy	21,800 +800	+4%	+$15.6K	﹤0.01%	1387
2016 Q2	$345K	Buy	+21,000	New	+$340K	﹤0.01%	1429
2015 Q4	–	Sell	-85,000	Closed	-$1.68M	–	1986
2015 Q3	$1.68M	Buy	+85,000	New	+$2.69M	0.01%	654
2014 Q4	–	Sell	-22,300	Closed	-$274K	–	1854
2014 Q3	$274K	Buy	+22,300	New	+$259K	﹤0.01%	1387

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

STRS Ohio's HZNP Position: Q4 2023 in Review

STRS Ohio sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 478,470 shares — an estimated $55.4M sold.

STRS Ohio first reported a position in HZNP in Q3 2014 and held it in 31 quarters. The position peaked at $80.1M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

STRS Ohio reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
STRS Ohio sold 478,470 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $55.4M.
STRS Ohio first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 31 quarters.
STRS Ohio's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $80.1M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.